Zoledronic Acid Dosing Interval for Metastatic Cancer Reply

被引：2
|
作者：
Himelstein, Andrew L. [1 ]
Loprinzi, Charles L. [2 ]
Shapiro, Charles L. [3 ]
机构：
[1] Helen F Graham Canc Ctr & Res Inst, 4701 Ogletown Stanton Rd,Ste 3400, Newark, DE 19713 USA
[2] Mayo Clin, Rochester, MN USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 317卷 / 14期
关键词：
BONE METASTASES;
D O I：
10.1001/jama.2017.2566
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1478 / 1478
页数：1
相关论文
共 50 条
  • [31] Zoledronic acid dosing frequency among older adults in the community
    Hayes, Kaleen
    Konstantelos, Natalia
    Cheung, Angela
    Cadarette, Suzanne
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 180 - 180
  • [32] Extended-interval dosing of natalizumab in NOVA Reply
    Foley, John F.
    Campbell, Nolan
    Kong, George
    LANCET NEUROLOGY, 2023, 22 (03): : 200 - 201
  • [33] Zoledronic acid—interdose interval of >1 year effective?
    Carol Wilson
    Nature Reviews Endocrinology, 2013, 9 (3) : 134 - 134
  • [34] Long interval zoledronic acid use in bone metastases
    Das, Manjulika
    LANCET ONCOLOGY, 2017, 18 (02): : E72 - E72
  • [35] Reply to Bone morphogenetic proteins and zoledronic acid
    Bertagna, X.
    Boudou-Rouquette, P.
    Alexandre, J.
    Soubtane, O.
    Goldwasser, F.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 2019 - 2019
  • [36] Electrolyte abnormalities with zoledronic acid therapy - Reply
    Rosen, LS
    CANCER JOURNAL, 2002, 8 (04): : 348 - 349
  • [37] Yearly zoledronic acid in postmenopausal osteoporosis - Reply
    Black, Dennis
    Eriksen, Erik
    Sellmeyer, Deborah
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (07): : 714 - 715
  • [38] Zoledronic acid in genitourinary cancer
    Climent, M. A.
    Anido, U.
    Mendez-Vidal, M. J.
    Puente, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (11): : 871 - 878
  • [39] Zoledronic acid in genitourinary cancer
    M. A. Climent
    U. Anido
    M. J. Méndez-Vidal
    J. Puente
    Clinical and Translational Oncology, 2013, 15 : 871 - 878
  • [40] Atypical Subtrochanteric Femur Fracture in Patient with Metastatic Breast Cancer Treated with Zoledronic Acid
    Kim, Yong-Seok
    Park, Woo-Chan
    JOURNAL OF BREAST CANCER, 2012, 15 (02) : 261 - 264
12345